Atlas FDA

Invenia ABUS Premium, Invenia ABUS Prime

FDA premarket approval P110006/S011 · decided 2025-02-04

Approval details

PMA number
P110006
Supplement
S011
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Invenia ABUS Premium, Invenia ABUS Prime
Generic name
Automated breast ultrasound
Applicant
GE Healthcare
Date received
2024-07-15
Decision date
2025-02-04
Days to decision
204 days
Decision code
APPR
Product code
PAA
Advisory committee
Radiology
Expedited review
No
Location
Wauwatosa, WI
Statement
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for modification of the currently-approved transducer, addition of a new transducer, hardware changes, addition of two new device names, and addition of two new features: Auto Nipple Detection, and Scan Quality Assessment.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
View (K253639)GE Healthcare2026-01-08
MR Contour DL (K242925)GE Healthcare2025-04-01
Digital Expert Access with Remote Scanning (K232346)GE Healthcare2023-10-27
Precision DL (K223212)GE Healthcare2023-04-27
Xeleris V Processing and Review System (K221680)GE Healthcare2023-03-01
Omni Legend (K221932)GE Healthcare2022-09-02
Voluson P6, Voluson P8 (K213689)GE Healthcare2022-02-17
Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert (K213642)GE Healthcare2022-01-13